Graeme Alexander

1982–2022 年に発表

86
論文数
22,792
被引用数
77
h 指数
86
i10 指数

被引用数

Graeme Alexander の年別被引用数1978 年: 被引用 1 件1979 年: 被引用 1 件1983 年: 被引用 2 件1984 年: 被引用 4 件1985 年: 被引用 2 件1986 年: 被引用 1 件1987 年: 被引用 8 件1988 年: 被引用 4 件1989 年: 被引用 9 件1990 年: 被引用 12 件1991 年: 被引用 28 件1992 年: 被引用 41 件1993 年: 被引用 44 件1994 年: 被引用 36 件1995 年: 被引用 57 件1996 年: 被引用 63 件1997 年: 被引用 43 件1998 年: 被引用 71 件1999 年: 被引用 75 件2000 年: 被引用 82 件2001 年: 被引用 57 件2002 年: 被引用 68 件2003 年: 被引用 102 件2004 年: 被引用 102 件2005 年: 被引用 120 件2006 年: 被引用 136 件2007 年: 被引用 140 件2008 年: 被引用 100 件2009 年: 被引用 135 件2010 年: 被引用 185 件2011 年: 被引用 191 件2012 年: 被引用 198 件2013 年: 被引用 228 件2014 年: 被引用 189 件2015 年: 被引用 230 件2016 年: 被引用 160 件2017 年: 被引用 156 件2018 年: 被引用 181 件2019 年: 被引用 523 件2020 年: 被引用 517 件2021 年: 被引用 522 件2022 年: 被引用 389 件2023 年: 被引用 298 件2024 年: 被引用 458 件2025 年: 被引用 210 件2026 年: 被引用 6 件1980〜1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,066 件、この内訳の 22.5%イギリス: 引用元論文 1,150 件、この内訳の 12.5%中国: 引用元論文 629 件、この内訳の 6.9%ドイツ: 引用元論文 535 件、この内訳の 5.8%イタリア: 引用元論文 516 件、この内訳の 5.6%フランス: 引用元論文 403 件、この内訳の 4.4%カナダ: 引用元論文 356 件、この内訳の 3.9%スペイン: 引用元論文 307 件、この内訳の 3.4%日本: 引用元論文 297 件、この内訳の 3.2%オランダ: 引用元論文 275 件、この内訳の 3%オーストラリア: 引用元論文 264 件、この内訳の 2.9%スイス: 引用元論文 194 件、この内訳の 2.1%
0%22.5%その他 23.8%

分野

  • Medicine71.4%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Immunology and Microbiology9%
  • Pharmacology, Toxicology and Pharmaceutics4.6%
  • Engineering0.9%
  • Neuroscience0.4%
  • その他1.4%

トピック

  • Liver Disease Diagnosis and Treatment10%
  • Hepatitis C virus research6.2%
  • Liver Disease and Transplantation5.3%
  • Liver Diseases and Immunity5.1%
  • Hepatitis B Virus Studies4.4%
  • Organ Transplantation Techniques and Outcomes3.1%
  • その他65.9%

共著者

全論文

検索で開く
  1. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2014 被引用: 617

  2. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ulrich Beuers, Rinse K. Weersma, Cisca Wijmenga, Hanns–Ulrich Marschall, Piotr Milkiewicz, Albert Parés, Kimmo Kontula, Olivier Chazouillères, Pietro Invernizzi, Elizabeth C. Goode, Kelly Spiess, Carmel Moore, Jennifer Sambrook, Willem H. Ouwehand, David J. Roberts, John Danesh, Annarosa Floreani, Aliya Gulamhusein, John E. Eaton, Stefan Schreiber, Catalina Coltescu, Christopher L. Bowlus, Velimir A. Luketic, Joseph A. Odin, Kapil Chopra, Kris V. Kowdley, Naga Chalasani, Michael P. Manns, Brijesh Srivastava, George Mells, Richard Sandford, Graeme Alexander, Daniel J. Gaffney, Roger W. Chapman, Gideon M. Hirschfield, Mariza de Andrade, Simon Rushbrook, André Franke, Tom H. Karlsen, Konstantinos N. Lazaridis, Carl A. Anderson - Nature Genetics 2016 被引用: 382

  3. Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan Davies, Kim B. Jensen, Matthias Zilbauer, William Gelson, Graeme Alexander, Sanjay Sinha, Nicholas R. F. Hannan, Thomas A. Wynn, Tom H. Karlsen, Espen Melum, Athina E. Markaki, Kourosh Saeb‐Parsy, Ludovic Vallier - Nature Medicine 2017 被引用: 294

  4. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

    著者: , , , , , , , , , , , , - Gut 2019 被引用: 287

  5. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease

    著者: , , , , , , , , , - Journal of Hepatology 2012 被引用: 313

  6. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

    著者: , , , , , , , , , , , , , - Gut 2018 被引用: 336

  7. Early indicators of prognosis in fulminant hepatic failure

    著者: , , , - Gastroenterology 1989 被引用: 2,104

  8. The UK‐PBC risk scores: Derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2015 被引用: 350

  9. Senescence in chronic liver disease: Is the future in aging?

    著者: , - Journal of Hepatology 2016 被引用: 165

  10. Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2018 被引用: 103

  11. Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression

    著者: , , , , , , - Cells 2022 被引用: 44

  12. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

    著者: , , , , , , , , , , , , , , , , , , - Nature 2009 被引用: 2,160

  13. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation

    著者: , , , , , , , , , , , , , , , , - Nature Biotechnology 2015 被引用: 395

  14. Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid

    著者: , , , , , , , , , , , - Gastroenterology 2012 被引用: 384

  15. Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease

    著者: , , , , , , , , , , - PLoS ONE 2013 被引用: 109

  16. Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study

    著者: , , , , , , , , , , , - Hepatology 2013 被引用: 218

  17. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

    著者: , , , , , , , , , , , , , , , , , - Science 2004 被引用: 1,190

  18. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter J.P. Croucher, Martina Sterneck, Andreas Teufel, Andrew L. Mason, Janna Saarela, Virpi Leppä, Ruslan Dorfman, Domenico Alvaro, Annarosa Floreani, Suna Önengüt-Gümüşcü, Stephen S. Rich, Wesley K. Thompson, Andrew J. Schork, Sigrid Næss, Ingo Thomsen, Gabriele Mayr, Inke R. König, Kristian Hveem, Isabelle Cleynen, Javier Gutierrez‐Achury, Isis Ricaño-Ponce, David A. van Heel, Einar Björnsson, Richard Sandford, Peter R. Durie, Espen Melum, Morten H. Vatn, Mark S. Silverberg, Richard H. Duerr, Leonid Padyukov, Stephan Brand, Miquel Sans, Vito Annese, Jean–Paul Achkar, Kirsten Muri Boberg, Hanns–Ulrich Marschall, Olivier Chazouillères, Christopher L. Bowlus, Cisca Wijmenga, Erik Schrumpf, Séverine Vermeire, Mario Albrecht, John D. Rioux, Graeme Alexander, Annika Bergquist, Judy H. Cho, Stefan Schreiber, Michael P. Manns, Martti Färkkilâ, Anders M. Dale, Roger W. Chapman, Konstantinos N. Lazaridis, André Franke, Carl A. Anderson, Tom H. Karlsen - Nature Genetics 2013 被引用: 398

  19. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eugenio Gaudio, Vincenzo Ronca, Giulia Bonato, Laura Cristoferi, Federica Malinverno, Alessio Gerussi, Deborah Stocken, Heather J. Cordell, Gideon M. Hirschfield, Graeme Alexander, Richard Sandford, David Jones, Pietro Invernizzi, George Mells, Caradog Thomas, Meshbah Rahman, Tom Yapp, Chin Lye Ch’ng, Melanie Harrison, Richard Sturgess, Roman Galaska, Chris Healey, Jessica Whiteman, Marek Czaijkowski, Catherine Gray, Anton Gunasekera, Pranab Gyawli, Purushothaman Premchand, Steven Mann, Keith Elliott, Kapil Kapur, Alan Watson, Graham R. Foster, Paul Trembling, Javaid Subhani, Rory Harvey, Roger McCorry, Carolyn Adgey, Lucie Hobson, Caroline Mulvaney-Jones, Richard J. Evans, Thiriloganathan Mathialahan, David Ramanaden, Jaber Gasem, Greta Van Duyvenvoorde, C Shorrock, Katie Seward, Paul Southern, Jeremy Tibble, Ruth Penn, David Gorard, Jane Maiden, Rose Damant, Altaf Palegwala, Susan Jones, Graeme Alexander, George Mells, Richard Sandford, Jessica Whiteman, Sunil Dolwani, Martin Prince, Valéria Damasceno Silvestre, Matthew Foxton, Eleanor Dungca, Harriet Mitchison, Natalie Wheatley, Ian Gooding, Helen Doyle, Mazn Karmo, Melanie Kent ほか 304 名 - ˜The œLancet. Gastroenterology & hepatology 2018 被引用: 163

  20. Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver

    著者: , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2022 被引用: 77

  21. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

    著者: , , , , , , , , , , , , , - Gut 2010 被引用: 345

  22. Ageing, telomeres, senescence, and liver injury

    著者: , , - Journal of Hepatology 2010 被引用: 179

  23. Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom

    著者: , , , , , , , , , - Clinical Gastroenterology and Hepatology 2018 被引用: 85

  24. Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - JHEP Reports 2021 被引用: 69